Xiangnan Liang
467 Zhongshan Road
Dalian, 116023, China
Dalian, 116023, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
EPHX1 enhances drug resistance to regorafenib by activating the JAK/STAT signaling pathway in hepatocellular carcinoma cell lines.
Journal: Hereditas
Published: April 14, 2025
RGS14 promotes the progression of hepatocellular carcinoma by activating the cAMP/PKA/CREB signaling pathway.
Journal: Journal of cancer research and clinical oncology
Published: March 22, 2025
METTL4 and METTL5 as biomarkers for recurrence-free survival in hepatocellular carcinoma patients.
Journal: Future oncology (London, England)
Published: December 20, 2024
Multi-omics pan-cancer study of SPTBN2 and its value as a potential therapeutic target in pancreatic cancer.
Journal: Scientific reports
Published: February 07, 2024
Integrated Bioinformatic Analysis Reveals the Oncogenic, Survival, and Prognostic Characteristics of TPX2 in Hepatocellular Carcinoma.
Journal: Biochemical genetics
Published: December 16, 2023
Potential prognostic biomarkers of hepatocellular carcinoma based on 4D label-free quantitative proteomics analysis pilot investigation.
Journal: The International journal of biological markers
Published: November 13, 2023
The potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapy.
Journal: Frontiers in oncology
Published: September 22, 2023
Risk Factors Related to Early Biliary Complications After Liver Transplantation: a Single-Center Analysis.
Journal: Transplantation proceedings
Published: July 23, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026